ATE209042T1 - Verwendung des wachstumshormons in mitteln zur behandlung der insulinresistenz im herzen - Google Patents
Verwendung des wachstumshormons in mitteln zur behandlung der insulinresistenz im herzenInfo
- Publication number
- ATE209042T1 ATE209042T1 AT98932685T AT98932685T ATE209042T1 AT E209042 T1 ATE209042 T1 AT E209042T1 AT 98932685 T AT98932685 T AT 98932685T AT 98932685 T AT98932685 T AT 98932685T AT E209042 T1 ATE209042 T1 AT E209042T1
- Authority
- AT
- Austria
- Prior art keywords
- heart
- growth hormone
- insulin resistance
- agents
- treating insulin
- Prior art date
Links
- 206010022489 Insulin Resistance Diseases 0.000 title abstract 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 title abstract 2
- 102000018997 Growth Hormone Human genes 0.000 title 1
- 108010051696 Growth Hormone Proteins 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 title 1
- 239000000122 growth hormone Substances 0.000 title 1
- 102000002265 Human Growth Hormone Human genes 0.000 abstract 1
- 108010000521 Human Growth Hormone Proteins 0.000 abstract 1
- 239000000854 Human Growth Hormone Substances 0.000 abstract 1
- 230000003915 cell function Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9702595A SE9702595D0 (sv) | 1997-07-04 | 1997-07-04 | new therapeutic use |
| SE9802023A SE9802023D0 (sv) | 1998-06-08 | 1998-06-08 | New therapeutic use |
| PCT/SE1998/001261 WO1999001151A1 (en) | 1997-07-04 | 1998-06-26 | Use of growth hormone in compositions for treating insulin resistance in the heart and for enhancing protein kinase b (pkb) activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE209042T1 true ATE209042T1 (de) | 2001-12-15 |
Family
ID=26663028
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98932685T ATE209042T1 (de) | 1997-07-04 | 1998-06-26 | Verwendung des wachstumshormons in mitteln zur behandlung der insulinresistenz im herzen |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1007085B1 (de) |
| JP (1) | JP2002511876A (de) |
| AT (1) | ATE209042T1 (de) |
| AU (1) | AU737065B2 (de) |
| CA (1) | CA2294824A1 (de) |
| DE (1) | DE69803298T2 (de) |
| DK (1) | DK1007085T3 (de) |
| ES (1) | ES2168772T3 (de) |
| NO (1) | NO20000007L (de) |
| NZ (1) | NZ501961A (de) |
| PT (1) | PT1007085E (de) |
| WO (1) | WO1999001151A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4669499A (en) * | 1998-06-08 | 1999-12-30 | Pharmacia & Upjohn Ab | New therapeutic use of pkb (proteine kinase b) enhancers |
| SE9901634D0 (sv) * | 1999-05-05 | 1999-05-05 | Sahltech Ab | Treatment of myocardial infarction with a substance related to the growth hormone axis |
| SE0000837D0 (sv) | 2000-03-13 | 2000-03-13 | Pharmacia & Upjohn Ab | New use |
| AU2006200127B2 (en) * | 2000-03-13 | 2007-10-25 | Pfizer Inc. | Use of growth hormone in low dose |
| WO2008027854A2 (en) * | 2006-08-31 | 2008-03-06 | Novartis Ag | Pharmaceutical compositions comprising hgh for oral delivery |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5935924A (en) * | 1994-04-15 | 1999-08-10 | Genentech, Inc. | Treatment of congestive heart failure |
| JPH09501533A (ja) * | 1994-04-18 | 1997-02-10 | ガイ フレール バーント エ エクスポルタシオン ソシエテ アノニム | 物体用電子メモリ素子 |
| EP0766966A3 (de) * | 1995-09-08 | 2001-02-28 | Eli Lilly And Company | Methode zur Behandlung der Insulinresistenz |
| SE9601397D0 (sv) * | 1996-04-12 | 1996-04-12 | Pharmacia Ab | Use of growth hormone |
-
1998
- 1998-06-26 NZ NZ501961A patent/NZ501961A/en unknown
- 1998-06-26 WO PCT/SE1998/001261 patent/WO1999001151A1/en not_active Ceased
- 1998-06-26 CA CA002294824A patent/CA2294824A1/en not_active Abandoned
- 1998-06-26 EP EP98932685A patent/EP1007085B1/de not_active Expired - Lifetime
- 1998-06-26 PT PT98932685T patent/PT1007085E/pt unknown
- 1998-06-26 DE DE69803298T patent/DE69803298T2/de not_active Expired - Fee Related
- 1998-06-26 ES ES98932685T patent/ES2168772T3/es not_active Expired - Lifetime
- 1998-06-26 JP JP50702099A patent/JP2002511876A/ja not_active Withdrawn
- 1998-06-26 AT AT98932685T patent/ATE209042T1/de not_active IP Right Cessation
- 1998-06-26 AU AU82506/98A patent/AU737065B2/en not_active Ceased
- 1998-06-26 DK DK98932685T patent/DK1007085T3/da active
-
2000
- 2000-01-03 NO NO20000007A patent/NO20000007L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1007085B1 (de) | 2001-11-21 |
| DE69803298T2 (de) | 2002-08-08 |
| ES2168772T3 (es) | 2002-06-16 |
| DE69803298D1 (de) | 2002-02-21 |
| JP2002511876A (ja) | 2002-04-16 |
| WO1999001151A1 (en) | 1999-01-14 |
| PT1007085E (pt) | 2002-05-31 |
| DK1007085T3 (da) | 2002-05-13 |
| NO20000007L (no) | 2000-03-06 |
| CA2294824A1 (en) | 1999-01-14 |
| EP1007085A1 (de) | 2000-06-14 |
| NO20000007D0 (no) | 2000-01-03 |
| AU8250698A (en) | 1999-01-25 |
| NZ501961A (en) | 2001-11-30 |
| AU737065B2 (en) | 2001-08-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ504026A (en) | Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C | |
| DE69838338D1 (de) | Verwendung von antimykotica zur topischen behandlung von pilz-induzierten schleimhautentzündungen | |
| DE69839529D1 (de) | Expressionsvektoren und zellinien zur expression von vaskulärem wachstumsfaktor d, sowie verfahren zur behandlung von melanomen | |
| IT1261949B (it) | Composizione terapeutica a base di interferone umano, impiego di interferone umano in tale composizione e relativo metodo. | |
| ATE342728T1 (de) | Zubereitung zur behandlung von einer neurologischen erkrankung | |
| DE69012261D1 (de) | Verwendung von Sertralin zur Behandlung verfrühter Ejakulation. | |
| ATE222488T1 (de) | Verwendung von anti-vegf-mitteln zur behandlung der endometriose | |
| ATE368455T1 (de) | Verwendung von (+)-tramadol, o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz | |
| MX9701187A (es) | Nuevas lactamas naftofusionadas n-substituidas. | |
| ATE209042T1 (de) | Verwendung des wachstumshormons in mitteln zur behandlung der insulinresistenz im herzen | |
| ATE281841T1 (de) | Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen | |
| ATE291918T1 (de) | Kombinationstherapie zur behandlung von tumoren | |
| ATE359808T1 (de) | Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma | |
| ATE297739T1 (de) | Endothelin-antagonisten zur behandlung von herzversagen | |
| DE60028559D1 (de) | Behandlung von multiplersklerose mit einer kombination von interferon und wachstumshormone | |
| DE69818809D1 (de) | Verfahren zur behandlung von narbengewebe | |
| DE69623316D1 (de) | Ctla-8 in kombination mit g-csf oder mit g-csf und il-6, und verwendung vom ctla-8 zur behandlung von infektionen | |
| DE69431430D1 (de) | Faktor XIII zur Behandlung von Hautwunden | |
| DE69734349D1 (de) | Behandlung von knochenleiden mit adrenomedullin | |
| ATE227991T1 (de) | Verwendung von topotecan in der behandlung von nichtkleinzelligen lungenkarzinomen | |
| DE69733321D1 (de) | Olanzapine zur behandlung von drogenmissbrauch | |
| ATE554787T1 (de) | Behandlung von typ-1-diabetes vor und nach der expression von prädispositionsmarkern | |
| DE69927599D1 (de) | Verwendung von wachstumshormon und analoga davon für die behandlung von säugern mit familiärer hypercholesterolämie | |
| WO1999013894A3 (en) | Use of ifn-alpha and amantadine for the treatment of chronic hepatitis c | |
| DE69430807D1 (de) | Verfahren zur behandlung von lebererkrankungen und ähnlichen indikationen mit vasodilatierenden wirkstoffen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |